23 January 2026, Singapore — As artificial intelligence reshapes how people seek medical information and care, Singapore’s Biomedical and Health Standards Committee convened its 16th meeting to ensure the nation’s standards framework keeps pace with this technological transformation.
The gathering at Spaces@Clarke Quay brought together leaders from government, academia, healthcare institutions, and industry under the chairmanship of Dr Yong Chern Chet. Against the backdrop of recent AI healthcare launches—including ChatGPT’s Health tab on 7 January and Anthropic’s Claude for Healthcare just days later on 12 January—the committee confronted a pivotal question: how can standardisation anticipate rather than react to an AI-first healthcare landscape?
“Standardisation must anticipate—not react to—AI-first healthcare,” Dr Yong emphasised in his opening remarks, noting that consumer behaviour is shifting rapidly as AI becomes many people’s first point of contact for medical information and preliminary assessment.
Recognising the People Behind the Progress
The meeting paused to celebrate the human effort driving Singapore’s standards ecosystem forward. Twenty-two BHSC partners received appreciation awards for exceptional contributions over the past year, with honourees spanning universities, hospitals, government agencies, biotech firms, and national bodies. The recognition reflects strong momentum across the community, with over half of all members achieving perfect participation across their committee responsibilities.
A Productive Year Draws to a Close
CoRE-SDO Head Ms Yang Fan delivered a comprehensive workplan update that painted a picture of steady progress. The committee has completed 14 standards toward its FY2025 target of 15, with major publications spanning medical device safety, sterilisation protocols, and healthcare interoperability. The final pending standard, SS ISO/FDIS 20417, remains on track for publication by March 2026.
The pipeline ahead looks equally ambitious. New initiatives include a work item proposal on AI bias management, a proposed standard for probiotics testing, and Singapore’s first regional standard on faecal microbiota transplant protocols. Notably, a Technical Reference on radiology AI evaluation has been strategically repositioned from a full standard to enable faster real-world testing and iteration.
The revision of TR67 on Connected medical device security may present an opportunity to develop a two-part standard that addresses both pre-market testing and post-market guidance.
Ms Yang reported that 66 standards now fall under BHSC’s purview—63 Singapore Standards and 3 Technical References—with six due for review in the coming year.
Confronting Systemic Challenges Head-On
Perhaps the meeting’s most consequential discussion centred on reforming how BHSC evaluates new work items. Ms Yang outlined persistent challenges that have hampered the committee’s agility: evaluation timelines stretching to three to five months instead of the intended one month, a 17-page proposal form placing heavy administrative burden on proposers, standards being withdrawn due to poor adoption, and the risk of SDO inadvertently becoming co-authors rather than neutral administrators.
The committee endorsed a streamlined two-stage evaluation framework designed to address these pain points. The first stage introduces “knock-out gates” where a concise 300-word abstract undergoes checks for policy compliance, duplication, focus, and redundancy. Proposals that clear these gates then advance to strategic scoring, where they are assessed against market demand and adoption potential, strategic alignment, economic and health impact, and international harmonisation. The weighting mechanism for these criteria remains under deliberation, but the refreshed process aims to make BHSC simultaneously more agile and more discerning.
Stepping Up on the World Stage
The meeting also affirmed Singapore’s growing ambitions in international standards leadership. The nation will elevate from Observer to Participating member status in ISO/TC 215, the international technical committee for health informatics—a move that grants Singapore a formal vote in shaping global health information standards.
CoRE-SDO has secured four expert seats for the April 2026 ISO/IEC JTC 1/SC 42/JWG 3 meeting on AI enabled health informatics hosted by IMDA, and will host the ISO/TC 212 plenary meeting on Medical laboratories and in vitro diagnostic systems in October 2026. Meanwhile, a promising whole genome sequence quality control standard developed by A*STAR’s Genome Institute of Singapore is on track to be proposed as a new ISO work item by May 2026.
The Road Ahead
The 16th BHSC meeting concluded with participants sharing a strong sense of mission: to ensure Singapore remains ahead of global trends in biomedical and health standards, particularly as AI and digital health technologies increasingly define how healthcare is delivered and experienced.